Literature DB >> 28182571

Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases.

Jakko van Ingen1,2, Dirk Wagner3,2, Jack Gallagher4, Kozo Morimoto5, Christoph Lange6,7,8,9, Charles S Haworth10, R Andres Floto10, Jennifer Adjemian11,12, D Rebecca Prevots11, David E Griffith13.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28182571     DOI： 10.1183/13993003.01855-2016

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  28 in total

Review 1.  [Nontuberculous mycobacteria in sputum : Recommendations for diagnosis and treatment].

Authors:  J Rademacher
Journal:  Internist (Berl)       Date:  2017-11       Impact factor: 0.743

Review 2.  NTM drug discovery: status, gaps and the way forward.

Authors:  Mu-Lu Wu; Dinah B Aziz; Véronique Dartois; Thomas Dick
Journal:  Drug Discov Today       Date:  2018-04-07       Impact factor: 7.851

Review 3.  Development of Drugs for Nontuberculous Mycobacterial Disease: Clinicians' Interpretation of a US Food and Drug Administration Workshop.

Authors:  Patrick A Flume; David E Griffith; James D Chalmers; Charles L Daley; Kenneth Olivier; Anne O'Donnell; Timothy Aksamit; Shannon Kasperbauer; Amy Leitman; Kevin L Winthrop
Journal:  Chest       Date:  2020-08-24       Impact factor: 9.410

4.  Annual prevalence estimation of lymphatic malformation with a cutaneous component: observational study of a national representative sample of physicians.

Authors:  Jack Ray Gallagher; J Martini; S Carroll; A Small; J Teng
Journal:  Orphanet J Rare Dis       Date:  2022-05-12       Impact factor: 4.303

Review 5.  Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK.

Authors:  Marc Lipman; Joanne Cleverley; Tom Fardon; Besma Musaddaq; Daniel Peckham; Roald van der Laan; Paul Whitaker; Jacqui White
Journal:  BMJ Open Respir Res       Date:  2020-06

6.  Longitudinal changes in health-related quality of life according to clinical course among patients with non-tuberculous mycobacterial pulmonary disease: a prospective cohort study.

Authors:  Nakwon Kwak; Sung A Kim; Sun Mi Choi; Jinwoo Lee; Chang-Hoon Lee; Jae-Joon Yim
Journal:  BMC Pulm Med       Date:  2020-05-07       Impact factor: 3.317

7.  Variability in the Management of Adults With Pulmonary Nontuberculous Mycobacterial Disease.

Authors:  Getahun Abate; Jack T Stapleton; Nadine Rouphael; Buddy Creech; Jason E Stout; Hana M El Sahly; Lisa Jackson; Francisco J Leyva; Kay M Tomashek; Melinda Tibbals; Nora Watson; Aaron Miller; Edward Charbek; Joan Siegner; Marcia Sokol-Anderson; Ravi Nayak; Greta Dahlberg; Pat Winokur; Ghina Alaaeddine; Nour Beydoun; Katherine Sokolow; Naomi Prashad Kown; Shanda Phillips; Arthur W Baker; Nicholas Turner; Emmanuel Walter; Elizabeth Guy; Sharon Frey
Journal:  Clin Infect Dis       Date:  2021-04-08       Impact factor: 20.999

8.  High mortality in patients with Mycobacterium avium complex lung disease: a systematic review.

Authors:  Roland Diel; Marc Lipman; Wouter Hoefsloot
Journal:  BMC Infect Dis       Date:  2018-05-03       Impact factor: 3.090

9.  Prevalence of nontuberculous mycobacteria in a tertiary hospital in Beijing, China, January 2013 to December 2018.

Authors:  Jing-Jing Huang; Ying-Xing Li; Ying Zhao; Wen-Hang Yang; Meng Xiao; Timothy Kudinha; Ying-Chun Xu
Journal:  BMC Microbiol       Date:  2020-06-12       Impact factor: 3.605

10.  Non-tuberculous mycobacterial lung disease in patients with bronchiectasis: perceived risk, severity and guideline adherence in a European physician survey.

Authors:  Dirk Wagner; Jakko van Ingen; Roald van der Laan; Marko Obradovic
Journal:  BMJ Open Respir Res       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.